MIM SurePlan MRT provides timesaving tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry for molecular radiotherapy.
MIM SurePlan MRT provides timesaving tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry for molecular radiotherapy.
MIM SurePlan LiverY90 provides timesaving tools for liver and tumor segmentation, deformable registration, and post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT.
MIM SurePlan LiverY90 provides timesaving tools for liver and tumor segmentation, deformable registration, and post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT.
Molecular Radiotherapies provide a distinct advantage over other systemic therapies:
their distribution can be seen and measured, enabling personalization. Absorbed dose
has shown to be a useful biomarker of response to radiation therapies. As a result, it has significant potential use in clinical decision-making to achieve the best possible patient outcomes. But is access to patient-specific absorbed dose practical?
MIM Software’s proprietary, gradientbased
technique segments lesions with
a single click.
Experience accurate and reproducible
tumor segmentation regardless of who
is doing the work.
Capture additional therapy response
metrics beyond tumor volume, such
as SUV peak and tumor burden.
support for quantitative SPECT reconstruction – ensuring that reconstruction can be performed on your existing cameras. having a vendor-neutral platform can help standardize reconstructions across your department.
Leveraging our experience in Radiation Oncology, MIM Software offers several industry-leading segmentation tools to help you save time in the dosimetry process. our new artificial intelligence platform for automatic segmentation of normal structures, and a single-click tool for tumor segmentation.
Single timepoint dosimetry is now available for evaluation in MIM SurePlan MRT. This is a cutting-edge dosimetry process that allows estimation of the absorbed dose with only a single SPECT/CT, further reducing the requirements needed to perform dosimetry.
Multiple Molecular Radiotherapy tracers, such as Lutathera Lu-177 dotatate, Azedra I-131 iobenguane, Hicon I-131 NAI for thyroid, and more can be imaged with MIM SurePlan MRT, confirming dose delivery in the patient.
Save time and improve accuracy over conventional registration techniques with MIM’s automatic image registration to propagate VOIs between timepoints with minimal or no adjustment.